Private company
BC Global Opportunities IX LP
Company in the British Virgin Islands. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersD81
Corporate structure
BC Global Opportunities IX LP sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- BC Global Opportunities IX LP D8
- BridgeBio Oncology Therapeutics, Inc. Stake ยท South San Francisco, California
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.
Filings
1 filings to the SEC since October 2021: 1 large holders. The latest 1:
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
1 such filings since October 2021:
- Mar 7, 2024SC 13G
Stakes it holds
BC Global Opportunities IX LP has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).
- BridgeBio Oncology Therapeutics, Inc.SCHEDULE 13G Sep 3, 20252
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2